Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
about
Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinomaIntra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and MetastasisInhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signalingUp-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathwayExpression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification.Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic NephropathyLoss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.Radiosensitisation of human glioma cells by inhibition of β1,6-GlcNAc branched N-glycans.Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cellsA novel monoclonal antibody to a defined peptide epitope in MUC16.GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.PTTG1 cooperated with GLI1 leads to epithelial-mesenchymal transition in esophageal squamous cell cancer.Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner.De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.Correlation of polypeptide N-acetylgalactosamine transferases-3 and -6 to different stages of endometriosis.Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer.Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers
P2860
Q27339711-B64AB86B-3310-4A94-9045-D2EAA8C6ED0DQ28066445-B83702CC-5FBF-48AF-8F75-B5F2A4D66D85Q33611054-091722CF-B9C7-422A-859E-0F17D80B422BQ34513833-3045FF91-15A5-4140-A115-4A12E2F119A7Q35742375-1619DC72-FEF0-430A-97FE-9238DC99935DQ35742481-675F154C-A804-4A0C-9316-4863479D108AQ36239980-A867859A-BF92-4641-9FB2-0F731CE97D39Q36328299-9306617D-B7F8-4029-B00A-E439D64DC293Q36410184-D760F8BF-9705-4349-B5CD-096E4B0AF60DQ36524003-F7D6D911-9E09-484F-B867-9D53F9356B75Q36544617-BB0E1568-182B-482B-97AD-2D93C04ECE87Q36889708-206C4913-05C8-4A88-A17D-21F954635B45Q37174016-E7C755A5-B20F-45F5-B218-E0C4288A17E2Q38203883-88FB627B-DE99-4CFF-AB44-8D1E58506702Q38821749-1F7F055D-DDDE-49E2-B44A-73E1C0CC5C8CQ38822766-5246DF41-0EB9-4170-A012-23A12FFFF799Q38966611-75B56855-9971-42A8-B8CD-ED4D50E9265CQ39837844-E98D567F-4C98-4230-A8D7-AF94FF859A5FQ40706867-5B6B3D3E-AF54-49AB-85DF-05CE9F083AE1Q42335706-69124E14-678F-4691-9390-6773F3E11313Q47105700-3B7EC33B-53A2-464D-A59E-59FADE056C78Q47107385-0362D419-0371-456C-81A2-EED12790DE4EQ47301558-AC34DD40-D1A3-4F82-AE48-7421DDC35149Q50746458-134BFFEB-521E-4D43-A942-A75C9912D42FQ55284634-0369F10C-3755-4CE2-A9B9-D089A7CE39BAQ58774191-FA18AF41-E5C8-4628-9564-D789BF3198A1
P2860
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the polypeptide N-acet ...... bnormal mucin O-glycosylation.
@en
Role of the polypeptide N-acet ...... bnormal mucin O-glycosylation.
@nl
type
label
Role of the polypeptide N-acet ...... bnormal mucin O-glycosylation.
@en
Role of the polypeptide N-acet ...... bnormal mucin O-glycosylation.
@nl
prefLabel
Role of the polypeptide N-acet ...... bnormal mucin O-glycosylation.
@en
Role of the polypeptide N-acet ...... bnormal mucin O-glycosylation.
@nl
P2093
P2860
P356
P1433
P1476
Role of the polypeptide N-acet ...... bnormal mucin O-glycosylation.
@en
P2093
Alexandra Sebastianelli
Chantale Morin
Jean Gregoire
Magdalena Bachvarova
Marie Plante
Marie-Claude Renaud
Zhi-Qiang Wang
P2860
P304
P356
10.18632/ONCOTARGET.1652
P407
P577
2014-01-01T00:00:00Z